Antoni Camins Selected Research

3- (3- chloro- 4- hydroxyphenylamino)- 4- (4- nitrophenyl)- 1H- pyrrole- 2,5- dione

9/2009	A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
5/2008	Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antoni Camins Research Topics

Disease

41	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 10/2003
23	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 04/2003
12	Cognitive Dysfunction 07/2021 - 08/2013
11	Inflammation (Inflammations) 12/2022 - 09/2012
8	Epilepsy (Aura) 01/2022 - 12/2009
8	Obesity 06/2020 - 10/2010
8	Nervous System Diseases (Neurological Disorders) 12/2019 - 10/2006
8	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2012 - 08/2007
8	Neuroblastoma 05/2011 - 03/2006
7	Parkinson Disease (Parkinson's Disease) 01/2020 - 04/2006
7	Amyloid Plaque 10/2019 - 11/2016
6	Neuroinflammatory Diseases 01/2022 - 06/2015
6	Gliosis 01/2016 - 07/2002
6	Huntington Disease (Huntington's Disease) 09/2010 - 06/2007
5	Insulin Resistance 12/2022 - 10/2013
5	Memory Disorders (Memory Loss) 04/2020 - 01/2013
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2010
5	Neoplasms (Cancer) 05/2019 - 10/2003
5	Seizures (Absence Seizure) 05/2017 - 12/2009
4	AIDS-Related Complex (ARC) 12/2019 - 09/2014
4	Temporal Lobe Epilepsy 08/2019 - 01/2018
3	Body Weight (Weight, Body) 01/2022 - 05/2017
3	Brain Diseases (Brain Disorder) 01/2021 - 01/2006
3	Dementia (Dementias) 01/2020 - 01/2018
3	Hypoxia (Hypoxemia) 01/2018 - 10/2006
2	Type 2 Diabetes Mellitus (MODY) 09/2021 - 10/2010
2	Status Epilepticus (Complex Partial Status Epilepticus) 05/2018 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2018
2	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 01/2017
2	Brain Injuries (Brain Injury) 02/2014 - 02/2010
2	Cardiomegaly (Heart Hypertrophy) 09/2013 - 12/2007
2	Bipolar Disorder (Manic Depressive Psychosis) 06/2009 - 01/2009
2	Ischemia 10/2006 - 01/2006
1	Glaucoma 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2019 - 08/2007
13	Amyloid (Amyloid Fibrils)IBA 10/2019 - 01/2011
9	ResveratrolIBA 01/2014 - 01/2008
8	Insulin (Novolin)FDA Link 12/2022 - 09/2014
8	Peptides (Polypeptides)IBA 01/2022 - 01/2006
8	Neuroprotective AgentsIBA 01/2022 - 11/2007
8	Phosphotransferases (Kinase)IBA 01/2021 - 06/2008
7	Pharmaceutical PreparationsIBA 10/2019 - 10/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2006
6	Kainic Acid (Kainate)IBA 08/2019 - 02/2014
6	3-nitropropionic acidIBA 09/2012 - 01/2006
6	Sirtuin 1IBA 04/2012 - 01/2008
5	CytokinesIBA 01/2021 - 02/2011
5	Memantine (Namenda)FDA Link 06/2020 - 10/2006
5	LeptinIBA 06/2017 - 01/2013
5	NeurotoxinsIBA 11/2010 - 01/2006
5	LithiumIBA 06/2010 - 06/2008
5	CalpainIBA 05/2010 - 01/2006
4	Therapeutic UsesIBA 09/2021 - 10/2003
4	Amyloid beta-PeptidesIBA 07/2021 - 01/2006
4	Protein Isoforms (Isoforms)IBA 12/2019 - 01/2017
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2012 - 10/2003
4	EnzymesIBA 10/2012 - 08/2007
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2011 - 01/2006
4	alvocidib (flavopiridol)IBA 08/2007 - 10/2003
3	dexibuprofenIBA 07/2021 - 01/2017
3	tau Proteins (tau Protein)IBA 01/2021 - 01/2018
3	Insulin ReceptorIBA 01/2020 - 09/2014
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2019 - 01/2006
3	Mitogen-Activated Protein KinasesIBA 11/2016 - 01/2009
3	SirtuinsIBA 04/2012 - 01/2008
3	MelatoninIBA 04/2012 - 04/2006
3	RoscovitineIBA 05/2011 - 10/2006
3	Glycogen Synthase Kinase 3IBA 05/2010 - 01/2009
2	LipidsIBA 01/2022 - 11/2007
2	masitinibIBA 01/2021 - 06/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2020 - 10/2017
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2020 - 01/2017
2	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 08/2014
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2019 - 01/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 03/2006
2	Free RadicalsIBA 01/2018 - 01/2018
2	Islet Amyloid PolypeptideIBA 12/2016 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 08/2013
2	Messenger RNA (mRNA)IBA 05/2015 - 07/2013
2	PolyphenolsIBA 09/2013 - 01/2008
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2013 - 09/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 05/2010
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 06/2009
2	PPAR alphaIBA 09/2012 - 12/2007
2	Glycogen Synthase (Synthase I)IBA 09/2012 - 05/2008
2	Taurine FDA Link 02/2011 - 12/2009
2	AntioxidantsIBA 01/2011 - 01/2006
2	Retinoblastoma ProteinIBA 11/2010 - 01/2008
2	Cell Cycle ProteinsIBA 11/2010 - 12/2003
2	CaspasesIBA 05/2010 - 01/2006
2	3- (3- chloro- 4- hydroxyphenylamino)- 4- (4- nitrophenyl)- 1H- pyrrole- 2,5- dioneIBA 09/2009 - 05/2008
2	Peptide Hydrolases (Proteases)FDA Link 06/2009 - 01/2006
2	calpain inhibitorsIBA 10/2006 - 01/2006
1	licochalcone AIBA 01/2022
1	PhycocyaninIBA 01/2022

Therapy/Procedure

11	Therapeutics 01/2020 - 10/2003
2	Intraperitoneal Injections 08/2019 - 05/2018
2	Caloric Restriction 10/2010 - 01/2008
1	Topical Administration 01/2022